Apoptosis-based therapies (original) (raw)

• Engelberg-Kulka, H. & Glaser, G. Addiction modules and programmed cell death and antideath in bacterial cultures. Annu. Rev. Microbiol. 53, 43–70 (1999).
  Article CAS PubMed Google Scholar
• Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456–1462 (1995).
  Article CAS PubMed Google Scholar
• Reed, J. C. Mechanisms of apoptosis. Am. J. Pathol. 157, 1415–1430 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Thornberry, N. & Lazebnik, Y. Caspases: enemies within. Science 281, 1312–1316 (1998).
  Article CAS PubMed Google Scholar
• Li, P. et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401–411 (1995).
  Article CAS PubMed Google Scholar
• Bergeron, L. et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev. 12, 1304–1314 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, S. et al. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501–509 (1998).
  Article CAS PubMed Google Scholar
• Ona, V. O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263–267 (1999).This paper showed that caspase inhibition could slow the progression of a chronic neurodegenerative disease in an animal model, and therefore strengthened the cause-and-effect linkage between caspases and severity or kinetics of neurodegeneration.
  Article CAS PubMed Google Scholar
• Endres, M. et al. Attentuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18, 238–247 (1998).
  Article CAS PubMed Google Scholar
• Holly, T. A. et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 31, 1709–1715 (1999).
  Article CAS PubMed Google Scholar
• Wiessner, C., Sauer, D., Alaimo, D. & Allegrini, P. R. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. Cell. Mol. Biol. 46, 53–62 (2000). | PubMed |
  CAS PubMed Google Scholar
• Rabuffetti, M. et al. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J. Neurosci. 20, 4398–4404 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Li, M. et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335–339 (2000).
  Article CAS PubMed Google Scholar
• Lee, D. et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7. J. Med. Chem. 44, 2015–2026 (2001).
  Article CAS PubMed Google Scholar
• Nicholson, D. W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000).
  Article CAS PubMed Google Scholar
• Reed, J. C. & Tomaselli, K. Drug discovery opportunities from apoptosis research. Curr. Opin. Biotechnol. 11, 586–592 (2000).
  Article CAS PubMed Google Scholar
• Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309–1312 (1998).
  Article CAS PubMed Google Scholar
• Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489 (1997).The first paper to describe the 'apoptosome' —a holoenzyme complex that maintains caspase-9 in an active conformation — and define its minimal components: APAF1, caspase-9 and cytochrome c.
  Article CAS PubMed Google Scholar
• Qin, H. et al. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399, 549–557 (1999).
  Article CAS PubMed Google Scholar
• Zou, H., Li, Y., Liu, X. & Wang, X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549–11556 (1999).
  Article CAS PubMed Google Scholar
• Saleh, A., Srinivasula, S., Acharya, S., Fishel, R. & Alnemri, E. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J. Biol. Chem. 274, 17941–17945 (1999).
  Article CAS PubMed Google Scholar
• Salvesen, G. S. & Dixit, V. M. Caspase activation: the induced-proximity model. Proc. Natl Acad. Sci. USA 96, 10964–10967 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Hakem, R. et al. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94, 339–352 (1998).
  Article CAS PubMed Google Scholar
• Chou, J., Matsuo, H., Duan, H. & Wagner, G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94, 171–180 (1998).
  Article CAS PubMed Google Scholar
• Ruland, J. et al. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell 104, 33–42 (2001).
  Article CAS PubMed Google Scholar
• Yeh, W. et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 1954–1958 (1998).
  Article CAS PubMed Google Scholar
• Zhang, J., Cado, C., Chen, A., Kabra, N. & Winoto, A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort 1. Nature 392, 296–299 (1998).
  Article CAS PubMed Google Scholar
• Kuang, A. A., Diehl, G. E., Zhang, J. & Winoto, A. FADD is required for DR4- and DR5-mediated apoptosis: lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J. Biol. Chem. 275, 25065–25068 (2000).
  Article CAS PubMed Google Scholar
• Deveraux, Q. & Reed, J. IAP family proteins: suppressors of apoptosis. Genes Dev. 13, 239–252 (1999).
  Article CAS PubMed Google Scholar
• La Casse, E. C., Baird, S., Korneluk, R. G. & MacKenzie, A. E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247–3259 (1998).
  Article Google Scholar
• Fesik, S. W. Insights into programmed cell death through structural biology. Cell 103, 273–282 (2000).
  Article CAS PubMed Google Scholar
• Yang, Y., Fang, S., Jensen, J., Weissman, A. & Ashwell, J. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874–877 (2000).
  Article CAS PubMed Google Scholar
• Ambrosini, G., Adida, C. & Altieri, D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 3, 917–921 (1997).The first report of the IAP-family member survivin, and the first study to show that some IAPs are over-produced in cancers.
  Article CAS PubMed Google Scholar
• Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S. & Dixit, V. M. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 10, 1359–1366 (2000).
  Article CAS PubMed Google Scholar
• Chen, J. et al. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2, 235–241 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Holcik, M. et al. The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury. Proc. Natl Acad. Sci. USA 97, 2286–2290 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Xu, D. G. et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med. 3, 997–1004 (1997).An early study that shows that gene-transfer-mediated elevations in the expression of IAP-family proteins can provide neuroprotection in vivo . This paper applied NAIP (the first human IAP to be discovered) in an animal model of cerebral ischaemia.
  Article CAS PubMed Google Scholar
• Xu, D. et al. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 19, 5026–5033 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Adams, J. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322–1326 (1998).
  Article CAS PubMed Google Scholar
• Gross, A., McDonnell, J. & Korsmeyer, S. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899–1911 (1999).
  Article CAS PubMed Google Scholar
• Huang, D. C. & Strasser, A. BH3-only proteins — essential initiators of apoptotic cell death. Cell 103, 839–842 (2000).
  Article CAS PubMed Google Scholar
• Dubois-Dauphin, M., Frankowski, H., Tsujimoto, Y., Huarte, J. & Martinou, J.-C. Neonatal motoneurons overexpressing the Bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl Acad. Sci. USA 91, 3309–3313 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Cenni, M. C. et al. Long-term survival of retinal ganglion cells following optic nerve section in adult Bcl-2 transgenic mice. Eur. J. Neurosci. 8, 1735–1745 (1996).
  Article CAS PubMed Google Scholar
• Linnik, M. D., Zahos, P., Geschwind, M. D. & Federoff, H. J. Expression of Bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 26, 1670–1674 (1995).
  Article CAS PubMed Google Scholar
• Kostic, V., Jackson-Lewis, V., de Bilbao, F., Dubois-Dauphin, M. & Przedborski, S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559–562 (1997).This report provided direct evidence that an apoptosis-blocking protein (BCL2) could prolong survival in an animal model of a chronic neurodegenerative disease, and therefore strengthened the cause-and-effect linkage between the apoptotic machinery and severity or kinetics of neurodegeneration.
  Article CAS PubMed Google Scholar
• Haldar, S., Jena, N. & Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA 92, 4507–4511 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Cheng, E. et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966–1968 (1997).
  Article CAS PubMed Google Scholar
• Sagot, S. et al. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7, 1313–1322 (1995).
  Article CAS PubMed Google Scholar
• Sattler, M. et al. Structure of Bcl-XL–Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983–986 (1997).The three-dimensional structure of BCL-X L bound to an inhibitory BH3 peptide laid the foundation for subsequent attempts to screen for, or derive by rational means, small-molecule antagonists of BCL2-family proteins.
  Article CAS PubMed Google Scholar
• Wang, J.-L. et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl Acad. Sci. USA 97, 7124–7129 (2000).This paper provided the first evidence that small-molecule inhibitors of BCL2 could be produced.
  Article CAS PubMed PubMed Central Google Scholar
• Degterev, A. et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL . Nature Cell Biol. 3, 173–182 (2001).
  Article CAS PubMed Google Scholar
• Tzung, S. et al. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nature Cell Biol. 3, 183–192 (2001).
  Article CAS PubMed Google Scholar
• Kroemer, G. & Reed, J. C. Mitochondrial control of cell death. Nature Med. 6, 513–519 (2000).
  Article CAS PubMed Google Scholar
• Bernardi, P. et al. The mitochondrial permeability transition. Biofactors 8, 273–281 (1998).
  Article CAS PubMed Google Scholar
• Sagot, Y. et al. An orally active anti-apoptotic molecule (CGP3466B) preserves mitochondria and enhances survival in an animal model of motoneuron disease. Br. J. Pharmacol. 131, 721–728 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Kragten, E. et al. Glyceraldehyde-3-phosphate dehydrogenase, the putative target of the anti-apoptotic compounds CGP3466 and _R_-(−)-deprenyl. J. Biol. Chem. 273, 5821–5826 (1998).
  Article CAS PubMed Google Scholar
• Tatton, W. G. & Chalmers-Redman, R. M. E. Modulation of gene expression rather than monoamine oxidase inhibition (−)-deprenyl-related compounds in controlling neurodegeneration. Neurology 47, S171–S183 (1996).
  Article CAS PubMed Google Scholar
• Yang, D. D. et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865–870 (1997).This work used a Jnk3 knockout mouse to validate this protein kinase as a potential drug discovery target for neuronal cell death.
  Article CAS PubMed Google Scholar
• Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94 (1997).
  Article CAS PubMed Google Scholar
• Geleziunas, R., Xu, W., Takeda, K., Ishijo, H. & Greene, W. C. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410, 834–838 (2001).
  Article CAS PubMed Google Scholar
• Kissil, J. L. & Kimchi, A. Death-associated proteins: from gene identification to the analysis of their apoptotic and tumour suppressive functions. Mol. Med. Today 4, 268–274 (1998).
  Article CAS PubMed Google Scholar
• Datta, S., Brunet, A. & Greenberg, M. Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927 (1999).
  Article CAS PubMed Google Scholar
• Wang, H.-G. et al. Calcineurin promotes apoptosis by dephosphorylating BAD. Science 284, 339–343 (1998).
  Article Google Scholar
• Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988–994 (2001).
  Article CAS PubMed Google Scholar
• Di Cristafano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100, 387–390 (2000).
  Article Google Scholar
• Kim, A. H., Khursigara, G., Sun, X., Franke, T. F. & Chao, M. V. AKT1 phosphorylates and negatively regulates ASK1. Mol. Cell. Biol. 21, 893–901 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Pekarsky, Y. et al. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl Acad. Sci. USA 98, 3690–3694 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728–1731 (2001).
  Article CAS PubMed Google Scholar
• Lietzke, S. E. et al. Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains. Mol. Cell 6, 385–394 (2000).
  Article CAS PubMed Google Scholar
• Neshat, M. S. et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl Acad. Sci. USA 98, 10314–10319 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Silverman, N. & Maniatis, T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321–2342 (2001).
  Article CAS PubMed Google Scholar
• Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J. & Cheng, G. NF-κB-mediated up-regulation of BCL-x and BFL-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl Acad. Sci. USA 96, 9136–9141 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Chu, Z. L. et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl Acad. Sci. USA 94, 10057–10062 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Stehlik, C. et al. Nuclear factor (NF)-κB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor-α-induced apoptosis. J. Exp. Med. 188, 211–216 (1998).This investigation showed a direct link between NF-κB and the expression of IAP-family genes, indicating that the induction of IAP expression represents an important mechanism by which NF-κB prevents TNFα-induced apoptosis in normal cells.
  Article CAS PubMed PubMed Central Google Scholar
• Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403, 103–108 (2000).Shows that certain types of prostaglandins (cyclopentone-type) directly inhibit IKKs. The study provided insights into the anti-inflammatory properties of some prostaglandins, and proposed routes to the discovery of small-molecule antagonists of IKKs.
  Article CAS PubMed Google Scholar
• Holmes-McNary, M. & Baldwin, A. S. J. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60, 3477–3483 (2000).
  CAS PubMed Google Scholar
• Sporn, M. B., Suh, N. & Mangelsdorf, D. J. Prospects for prevention and treatment of cancer with SPARMs (selective PPARγ modulators). Trends Mol. Med. 7, 395–400 (2001).
  Article CAS PubMed Google Scholar
• Adams, J., Palombella, V. J. & Elliott, P. J. Proteasome inhibition: a new strategy in cancer treatment. Invest. New Drugs 18, 109–121 (2000).
  Article CAS PubMed Google Scholar
• Thompson, W. J., et al. Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin. Cancer Res. 60, 3338–3342 (2000).
  CAS PubMed Google Scholar
• Goluboff, E. T. et al. Safety and efficacy of Exisulind for treatment of recurrent prostate cancer after radical prostatectomy. J. Urol. 166, 882–886 (2001).
  Article CAS PubMed Google Scholar
• Pratt, M. A. C. et al. Bcl-2 is required to prevent estrogen withdrawal-induced human breast cancer tumour regression. FEBS Lett. 440, 403–408 (1998).
  Article CAS PubMed Google Scholar
• Andreeff, M. et al. Expression of Bcl-2 family genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia 13, 1881–1892 (1999).
  Article CAS PubMed Google Scholar
• Blutt, S. E., McDonnell, T. J., Polek, T. C. & Weigel, N. L. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology 141, 10–17 (2000).
  Article CAS PubMed Google Scholar
• Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D. & DuBois, R. N. Modulation of apoptosis and Bcl-2 expression by progtaglandin E2 in human colon cancer cells. Cancer Res. 58, 362–366 (1998).
  CAS PubMed Google Scholar
• Tsujii, M. & DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493–501 (1995).
  Article CAS PubMed Google Scholar
• Zhang, L., Yu, J., Park, B. H., Kinzler, K. W. & Vogelstein, B. Role of BAX in the apoptotic response to anticancer agents. Science 290, 989–992 (2000).
  Article CAS PubMed Google Scholar
• Sun, M. et al. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor-α (ERα) via interaction between ERα and PI3K. Cancer Res. 61, 5985–5991 (2001).
  CAS PubMed Google Scholar
• Kousteni, S. et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719–730 (2001).A study that provided in vivo evidence that steroid-hormone receptors can have transcription-independent mechanisms linked to apoptosis regulation.
  CAS PubMed Google Scholar
• Li, H. et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289, 1159–1164 (2000).Showed that steroid/retinoid-family transcription factors can function outside the nucleus to regulate apoptosis, indicating opportunities for the development of small-molecule drugs that modulate this non-nuclear, non-transcriptional activity.
  Article CAS PubMed Google Scholar
• Brenner, C. & Kroemer, G. Apoptosis. Mitochondria — the death signal integrators. Science 289, 1150–1151 (2000).
  Article CAS PubMed Google Scholar
• Richon, V. M., Zhou, X., Rifkind, R. A. & Marks, P. A. Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers. Blood Cells Mol. Dis. 27, 260–264 (2001).
  Article CAS PubMed Google Scholar
• Grooteclaes, M. L. & Frisch, S. M. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene 19, 3823–3828 (2000).
  Article CAS PubMed Google Scholar
• Bischoff, J. R. et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373–376 (1996).Revealed that a mutant adenovirus only replicates in p53-deficient cells, setting the stage for subsequent clinical trials that were intended to exploit this property for treating cancer patients with p53-deficient tumours.
  Article CAS PubMed Google Scholar
• Khuri, F. R. et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Med. 6, 879–885 (2000).
  Article CAS PubMed Google Scholar
• Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of human BAX gene. Cell 80, 293–299 (1995).This report provided the first evidence that p53 directly binds to the promoter of a pro-apoptotic gene ( BAX ) and induces its transcription, thereby providing the first direct link between p53 and the apoptosis machinery. Subsequently, p53 was shown to directly transactivate several pro-apoptotic genes, including other members of the BCL2 family and some of the TNF-family of death receptors.
  Article CAS PubMed Google Scholar
• Oda, E. et al. NOXA, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053–1058 (2000).
  Article CAS PubMed Google Scholar
• Nakano, K. & Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683–694 (2001).
  Article CAS PubMed Google Scholar
• Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673–682 (2001).
  Article CAS PubMed Google Scholar
• Owen-Schaub, L. B. et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15, 3032–3040 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Wu, G. S. et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nature Genet. 17, 141–143 (1997).
  Article CAS PubMed Google Scholar
• Roth, J. A., Swisher, S. G. & Meyn, R. E. p53 tumor suppressor gene therapy for cancer. Oncology 13, 148–154 (1999).
  CAS PubMed Google Scholar
• Foster, B., Coffey, H., Morin, M. & Rastinejad, F. Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507–2510 (1999).
  Article CAS PubMed Google Scholar
• Komarov, P. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733–1737 (1999).
  Article CAS PubMed Google Scholar
• Ashkenazi, A. & Dixit, V. M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255–260 (1999).
  Article CAS PubMed Google Scholar
• Pedersen, I. M., Buhl, A. M., Klausen, P., Geisler, C. H. & Jurlander, J. The chimeric anti-CD20 antibody Rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 MAP-kinase dependent mechanism. Blood (in the press).
• Byrd, J. C. et al. The mechanism of tumor cell clearance by Rituximab in vivo in patients with B-cell chronic lymphocytic leukemia involves apoptosis via a caspase-9 pathway. Blood (in the press).
• Gutheil, J. C. et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin αvβ3 . Clin. Cancer Res. 6, 3056–3061 (2000).
  CAS PubMed Google Scholar
• Digicaylioglu, M. & Lipton, S. A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412, 641–647 (2001).This paper showed a neuroprotective effect for erythropoietin, indicating possibilities of a new clinical application for this growth factor.
  Article CAS PubMed Google Scholar
• Ray, J. & Gage, P. H. Construction of cells expressing neurotrophins. Methods Mol. Biol. 169, 115–133 (2001).
  CAS PubMed Google Scholar
• Paris, F. et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293–297 (2001).
  Article CAS PubMed Google Scholar
• Gottlieb, R., Giesing, H., Zhu, J., Engler, R. & Babior, B. Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H+-ATPase. Proc. Natl Acad. Sci. USA 92, 5965–5968 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, J. et al. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J. Biol. Chem. 272, 15434–15441 (1997).
  Article CAS PubMed Google Scholar
• Nakagawa, T. et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98–103 (2000).Suggested a pathway that links stress in the endoplasmic reticulum (ER) to caspase activation.
  Article CAS PubMed Google Scholar
• Mancini, M. et al. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J. Cell Biol. 149, 603–612 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Z.-G. et al. PML is essential for multiple apoptotic pathways. Nature Genet. 20, 266–272 (1998).
  Article CAS PubMed Google Scholar
• Hess, J. L. & Korsmeyer, S. J. Life, death and nuclear spots. Nature Genet. 20, 220–222 (1998).Provided in vivo evidence that the nuclear protein PML modulates the apoptosis-sensitivity of cells.
  Article CAS PubMed Google Scholar
• Riedl, S. J. et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104, 791–800 (2001).
  Article CAS PubMed Google Scholar
• Du, C., Fang, M., Li, Y., Li, L. & Wang, X. SMAC, a mitochondrial protein that promotes cytochrome _c_-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33–42 (2000).
  Article CAS PubMed Google Scholar
• Verhagen, A. M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53 (2000).References 118 and 119 describe the discovery of a mitochondrial protein that is released into the cytosol during apoptosis, and which binds and inhibits IAP-family proteins. Subsequent structural studies of these endogenous IAP antagonists indicated a possible way of discovering small-molecule mimics.
  Article CAS PubMed Google Scholar
• Suzuki, Y. et al. A serine protease HTRA2/Omi, which is released from the mitochondria and interacts with XIAP, induces caspase-independent cell death. Mol. Cell 8, 613–621 (2001).
  Article CAS PubMed Google Scholar
• Srinivasula, S. M. et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410, 112–116 (2001)
  Article CAS PubMed Google Scholar